Disease management
SugoSure targets patients with type 2 diabetes below 65 years old.
The consumer app enables users to monitor their own heart rhythm round the clock.
Impeto’s SUDOSCAN technology for monitoring peripheral neuropathies is included in Withings’ recently announced Body Scan smart scale.
The company said the smart scale will be available in the latter half of 2022 following regulatory clearance.
2022 Look Ahead
After another rough year for the healthcare system, startups are using the growth of virtual care to manage chronic conditions and expand primary care.
The research targets people with complex regional pain syndrome, post-stroke pain, and other pain-induced conditions.
The company emerged from stealth in August with $41 million.
Also, AXA Hong Kong is offering limited time free trial of Mind Healer online mental health consultation on its mobile app.
The digital tool will be first marketed in Taiwan following regulatory approvals.
Its digital wound care toolkit is targeted to be rolled out in 2026.